Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NBY
NBY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NBY News
Netflix Reports Q4 Results, Q1 Guidance Misses Estimates
Jan 21 2026
Benzinga
D.R. Horton Reports Q1 Net Income of $594.8M Exceeding Estimates
Jan 20 2026
Benzinga
NovaBay Pharmaceuticals (NBY) Announces $100M Stock Sale Agreement with Virtu Americas
Jan 20 2026
seekingalpha
J.B. Hunt Reports Q4 Revenue Slightly Below Estimates, Shares Drop 4.2%
Jan 16 2026
Benzinga
RF Industries Reports $22.7M Q4 Sales, Shares Surge 21.4%
Jan 15 2026
Benzinga
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1%
Jan 14 2026
Benzinga
Dow Jones Falls Over 250 Points as Financial Stocks Decline
Jan 12 2026
Benzinga
CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026
Jan 09 2026
Benzinga
Cybin Inc Launches $100 Million Equity Program, Shares Drop 6.6%
Dec 31 2025
Benzinga
Indaptus Therapeutics Completes Board Restructuring and Raises $6 Million
Dec 24 2025
Benzinga
Reviva Pharmaceuticals Shares Plunge 45.9%, Dragging Down Drug Sector
Dec 23 2025
NASDAQ.COM
UniFirst Corp Receives $275 Acquisition Proposal from Cintas, Valuing Company at $5.2 Billion
Dec 22 2025
Benzinga
Carnival Reports Robust Q4 Earnings, Alongside Amicus Therapeutics, Biomarin Pharmaceutical, and Other Major Stocks Rising on Friday
Dec 19 2025
Benzinga
NioBay Metals Closes C$8.5M Financing to Advance James Bay Project
Dec 18 2025
Newsfilter
Cementos Pacasmayo, Rezolve AI, Emerald Holding, and Other Major Stocks Rising on Monday
Dec 16 2025
Benzinga
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
Dec 15 2025
Benzinga
Show More News
